Clinical Trial

Light-based Immunomodulation for Guarding Against Human Respiratory Tract Infections

Name: Light-based Immunomodulation for Guarding Against Human Respiratory Tract Infections — clinical trial record (NCT07610967)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: LIGHT

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

The purpose of trial is to determine if daily usage of a photobiomodulation device will decrease the incidence of upper respiratory tract infections (URI) due to COVID, influenza or other viruses.The RD-X10 device is handheld, can be self-administered, and has been shown to be safe in invivo studies.

Trial Details

NCT Number	NCT07610967
Lead Sponsor	David Moss
Conditions	COVID-19 Respiratory Infection, Influenza
Enrollment	130 participants
Start Date	2026-06
Primary Completion	2028-06 (estimated)
Study Completion	2028-06 (estimated)
Updated on ClinicalTrials.gov	2026-05-28